← Eichor
Condition: Early Stage Non Small Cell Lung Cancer Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Early Stage Non Small Cell Lung Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Phase 3 Study of Sunvozertinib Versus Placebo as Adjuvant Therapy in Patients With Early-Stage Non-Small Cell Lung Can
Phase 3 · 49 location(s) · Dizal (Jiangsu) Pharmaceutical Co., Ltd. · NCT07182682Multiomics Tumor Evolution Model of NSCLC
Phase N/A · 1 location(s) · Peking University People's Hospital · NCT05352035Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) - a Combined Epigenetic-Immun
Phase 1/Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT06694454Cell Free DNA for the Diagnosis and Treatment in Early NSCLC
Phase N/A · 1 location(s) · Samsung Medical Center · NCT03791034MONDRIAN: Multi-omics Integrative Modelling for Stereotactic Body Radiotherapy in Early-stage Non-small Cell Lung Cancer
Phase N/A · 2 location(s) · European Institute of Oncology · NCT05974475Neoadjuvant Dupilumab and Cemiplimab in Patients With Early-stage Resectable NSCLC
Phase 1/Phase 2 · 1 location(s) · Icahn School of Medicine at Mount Sinai · NCT06088771IPH5201 and Durvalumab in Patients With Resectable Non-Small Cell Lung Cancer (MATISSE)
Phase 2 · 30 location(s) · Innate Pharma · NCT05742607The Impact of Surgical Technique on Circulating Tumor DNA in Stage I-III Non-Small Cell Lung Cancer
NA · 4 location(s) · Thomas Jefferson University · NCT05502523Electroacupuncture Combined With Immune Checkpoint Inhibitors as Adjuvant Therapy After Surgery for Early-stage Non-smal
Phase 2/Phase 3 · 1 location(s) · Kong Fanming · NCT07034326A Machine Learning Approach to Identify Patients With Resected Non-small-cell Lung Cancer With High Risk of Relapse
Phase N/A · 1 location(s) · University Hospital, Toulouse · NCT05732974Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harbor
Phase 3 · 199 location(s) · Boehringer Ingelheim · NCT07195695To Explore the Safety and Efficacy of Hypervision Proton Surgery for Early-stage Non-small Cell Lung Cancer
NA · 1 location(s) · Anhui Provincial Cancer Hospital · NCT07195084Study of Tarlatamab as Maintenance Treatment After Chemo-radiotherapy for Limited Stage SCLC Patients
Phase 2 · 20 location(s) · Fundación GECP · NCT07242547Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
Phase 2 · 97 location(s) · AstraZeneca · NCT05061550Near-Infrared Fluorescence Guided Robotic Pulmonary Segmentectomy for Early Stage Lung Cancer
Phase 1 · 1 location(s) · St. Joseph's Healthcare Hamilton · NCT02570815Study Comparing Two Different Schedules of Radiation for Early-stage Lung Cancer
NA · 1 location(s) · University of Rochester · NCT03706027Elimination of PTV Margins Based on Online Adaptive Stereotactic Radiotherapy for Early-stage Non-small Cell Lung Cancer
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT06542159A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Diseas
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT07323732Quality of Life Intervention to Inform Patient Decision-Making in Early-Stage Lung Cancer
NA · 1 location(s) · Roswell Park Cancer Institute · NCT05292521Multi-omics Study of Early-stage Lung Cancer With Distinct Phenotypes
Phase N/A · 1 location(s) · Central South University · NCT06699979Safety Trial of Antimicrobial Therapy and Precision Radiation Therapy in Patients With Oligoprogressive Non-small Cell L
Phase 1 · 1 location(s) · Abramson Cancer Center at Penn Medicine · NCT03546829A Study of Ivonescimab in People With Non-Small Cell Lung Cancer
Phase 1/Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT07594522Carbon Ion Therapy for Peripheral Non-small Cell Lung Cancer
Phase 2 · 1 location(s) · Shanghai Proton and Heavy Ion Center · NCT05613452Early Feasibility Study (EFS) of the 'CAROL' for Treatment of Lung Cancer Stage 1
NA · 1 location(s) · Tau Medical Australia Pty Ltd · NCT07122258Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer
Phase 3 · 20 location(s) · National Cancer Institute (NCI) · NCT07388524Honokiol in Early-Stage Resectable Non-Small Cell Lung Cancer
Phase 1 · 1 location(s) · The Methodist Hospital Research Institute · NCT06566443Elimination of PTV Margins Based on Online Adaptive Stereotactic Radiotherapy for Centrally Located Early-stage Non-smal
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT06730295A Study to Evaluate the Benefit of Adding Durvalumab After Chemotherapy, Durvalumab and Surgery in Patients With Early-s
Phase 3 · 42 location(s) · ETOP IBCSG Partners Foundation · NCT06284317ELobectomy for NSCLC by VATS Versus Thoracotomy (ECTOP-1007)
NA · 1 location(s) · Fudan University · NCT03786003ctDNA to Predict Response to Chemo-Immunotherapy and Detect Minimal Residual Disease in Non-Small Cell Lung Cancer
Phase 2 · 1 location(s) · University of Miami · NCT06902272
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.